Brown G P, Douglas J G
Endocrinology. 1983 Jun;112(6):2007-14. doi: 10.1210/endo-112-6-2007.
In the kidney, angiotensin II influences reabsorptive processes by a direct tubular effect(s). The receptors mediating the response may be located on either the luminal (brush border) and/or the contraluminal (basolateral) membranes of the tubular epithelial cells. In the studies reported here, we identify specific [125I]angiotensin II-binding sites in rat and baboon tubular basolateral membranes. Specific binding was saturable, largely reversible, and proportional to membrane protein concentration. Structural specificity was confirmed by the use of angiotensin analogs and structurally unrelated polypeptides. The latter did not compete with radioligand for binding. Scatchard analyses of binding inhibition data indicated a single class of high affinity sites in rat (Kd = 2.2 +/- 0.2 nM; n = 12) and two classes of sites in baboon [Kd = 1.32 (n = 1) and 0.6 +/- 0.1 nM; n = 2) basolateral membranes. The binding site concentrations were 929 +/- 138 fmol/mg protein (rat) and 463 and 439 +/- 120 fmol/mg protein (baboon). Rat binding sites were affected by the addition of cations, as chloride salts, to the incubation medium. Na+ (100-200 mM) decreased the Kd from 4.2 +/- 0.4 nM in the absence of cations to 2.7 +/- 0.3 nM (n = 4). Mg2+ (4 mM) had no effect on Kd, but increased the binding site concentration from 556 +/- 84 to 915 +/- 166 fmol/mg protein. In contrast, 2 mM Ca2+ increased the Kd to 5.3 +/- 0.6 nM, and Mg2+ and Ca2+ added together affected neither Kd nor number of binding sites. Bound (eluted from membranes) and free (in medium) radioactivity, after incubation with membranes to steady state, were 54-68% (n = 3) and 85% (n = 2) intact [125I] angiotensin II, respectively, as determined by rebinding to fresh membranes. These data are inconsistent with binding to a degradative enzyme and indicate the presence of specific [125I] angiotensin II-binding sites in renal tubular basolateral membranes.
在肾脏中,血管紧张素II通过直接的肾小管效应影响重吸收过程。介导该反应的受体可能位于肾小管上皮细胞的管腔(刷状缘)和/或对侧管腔(基底外侧)膜上。在本文报道的研究中,我们在大鼠和狒狒的肾小管基底外侧膜中鉴定出了特异性的[125I]血管紧张素II结合位点。特异性结合是可饱和的,在很大程度上是可逆的,并且与膜蛋白浓度成正比。通过使用血管紧张素类似物和结构不相关的多肽证实了结构特异性。后者不与放射性配体竞争结合。对结合抑制数据进行Scatchard分析表明,大鼠的基底外侧膜中有一类高亲和力位点(Kd = 2.2±0.2 nM;n = 12),狒狒的基底外侧膜中有两类位点[Kd = 1.32(n = 1)和0.6±0.1 nM;n = 2]。结合位点浓度分别为929±138 fmol/mg蛋白(大鼠)和463以及439±120 fmol/mg蛋白(狒狒)。向孵育培养基中添加阳离子(以氯化物盐形式)会影响大鼠的结合位点。Na+(100 - 200 mM)可使Kd从无阳离子时的4.2±0.4 nM降至2.7±0.3 nM(n = 4)。Mg2+(4 mM)对Kd无影响,但可使结合位点浓度从556±84增加至915±166 fmol/mg蛋白。相比之下,2 mM Ca2+可使Kd增加至5.3±0.6 nM,同时添加Mg2+和Ca2+对Kd和结合位点数量均无影响。与膜孵育至稳态后,从膜上洗脱下来的结合放射性和培养基中的游离放射性,经重新与新鲜膜结合测定,分别有54 - 68%(n = 3)和85%(n = 2)的[125I]血管紧张素II保持完整。这些数据与与降解酶的结合不一致,表明肾小管基底外侧膜中存在特异性的[125I]血管紧张素II结合位点。